Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2020
Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of TransplantationDavid Kliman, Ian Nivison-Smith, David Gottlieb, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 9, 2020
The QuantiFERON Monitor® assay is predictive of infection post allogeneic hematopoietic cell transplantationAbby P Douglas, Lijia Yu, Vijaya Sundararajan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Relative survival of long-term hematopoietic cell transplant recipients approaches general population ratesIan Nivison-Smith, Judy M Simpson, Anthony J Dodds, et al.
Leukemia & Lymphoma|January 5, 2013
A population-based analysis of the effect of autologous hematopoietic cell transplant in the treatment of multiple myelomaIan Nivison-Smith, Judy M Simpson, Anthony J Dodds, et al.
Transplantation|May 3, 2016
Safety of Living Donation of Hematopoietic Stem CellsJeff Szer, Heidi Elmoazzen, Mirjam Fechter, et al.
British Journal of Haematology|May 29, 2010
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapyMichael Dickinson, Rosemary Hoyt, Andrew W Roberts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 20, 2015
A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013Ian Nivison-Smith, Peter Bardy, Anthony J Dodds, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality riskIan Nivison-Smith, Anthony J Dodds, Jason Butler, et al.
European Journal of Haematology|January 31, 2022
Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuriaAustin Kulasekararaj, Axel Glasmacher, Peng Liu, et al.
Pageof 15